Search research articles
Contact Us
Filters
Showing results (101-110 of 255) with videos related to
Page
of 26
Sort By:
CNS Neuroscience & Therapeutics
|
November 21, 2015
Long-Term Effects of Repeated Cycles of Intrathecal Triamcinolone Acetonide on Spasticity in MS Patients
Paulus Stefan Rommer, Frank Kamin, Mazen Abu-Mugheisib, et al.
European Journal of Clinical Investigation
|
April 15, 2015
Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis--an observational study
Paulus S Rommer, Karoline Buckow, David Ellenberger, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
October 8, 2013
Simulation of plastic surgery and microvascular procedures using perfused fresh human cadavers
Joseph N Carey, Elizabeth Rommer, Clifford Sheckter, et al.
Acta Neurologica Scandinavica
|
November 18, 2018
Do elevated autoantibodies in patients with multiple sclerosis matter?
Assunta Dal-Bianco, Fritz Wenhoda, Paulus Stefan Rommer, et al.
Molecular Carcinogenesis
|
December 11, 2014
Induction of the proapoptotic tumor suppressor gene Cell Adhesion Molecule 1 by chemotherapeutic agents is repressed in therapy resistant acute myeloid leukemia
Muriel C Fisser, Anna Rommer, Katarina Steinleitner, et al.
Spinal Cord
|
September 17, 2014
Effects of intrathecal triamincinolone-acetonide treatment in MS patients with therapy-resistant spasticity
F Kamin, P S Rommer, M Abu-Mugheisib, et al.
Eye and Brain
|
March 19, 2021
Evaluation of Retinal Layer Thickness Parameters as Biomarkers in a Real-World Multiple Sclerosis Cohort
Natascha Schurz, Lydia Sariaslani, Patrick Altmann, et al.
Scientific Reports
|
October 21, 2024
The presence of oligoclonal bands predicts conversion to multiple sclerosis in isolated myelitis
Tobias Monschein, Markus Ponleitner, Gabriel Bsteh, et al.
Scientific Reports
|
October 3, 2024
Investigation of serum neurofilament light chain as a biomarker in Fabry disease
Markus Ponleitner, Constantin Gatterer, Gabriel Bsteh, et al.
Journal of Neurology
|
September 15, 2020
Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis
Tobias Monschein, Sabine Salhofer-Polanyi, Patrick Altmann, et al.
Page
of 26
Search research articles
Search
Showing results (101-110 of 255) with videos related to
Sort By:
Page
of 26
CNS Neuroscience & Therapeutics
|
November 21, 2015
Long-Term Effects of Repeated Cycles of Intrathecal Triamcinolone Acetonide on Spasticity in MS Patients
Paulus Stefan Rommer, Frank Kamin, Mazen Abu-Mugheisib, et al.
European Journal of Clinical Investigation
|
April 15, 2015
Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis--an observational study
Paulus S Rommer, Karoline Buckow, David Ellenberger, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
October 8, 2013
Simulation of plastic surgery and microvascular procedures using perfused fresh human cadavers
Joseph N Carey, Elizabeth Rommer, Clifford Sheckter, et al.
Acta Neurologica Scandinavica
|
November 18, 2018
Do elevated autoantibodies in patients with multiple sclerosis matter?
Assunta Dal-Bianco, Fritz Wenhoda, Paulus Stefan Rommer, et al.
Molecular Carcinogenesis
|
December 11, 2014
Induction of the proapoptotic tumor suppressor gene Cell Adhesion Molecule 1 by chemotherapeutic agents is repressed in therapy resistant acute myeloid leukemia
Muriel C Fisser, Anna Rommer, Katarina Steinleitner, et al.
Spinal Cord
|
September 17, 2014
Effects of intrathecal triamincinolone-acetonide treatment in MS patients with therapy-resistant spasticity
F Kamin, P S Rommer, M Abu-Mugheisib, et al.
Eye and Brain
|
March 19, 2021
Evaluation of Retinal Layer Thickness Parameters as Biomarkers in a Real-World Multiple Sclerosis Cohort
Natascha Schurz, Lydia Sariaslani, Patrick Altmann, et al.
Scientific Reports
|
October 21, 2024
The presence of oligoclonal bands predicts conversion to multiple sclerosis in isolated myelitis
Tobias Monschein, Markus Ponleitner, Gabriel Bsteh, et al.
Scientific Reports
|
October 3, 2024
Investigation of serum neurofilament light chain as a biomarker in Fabry disease
Markus Ponleitner, Constantin Gatterer, Gabriel Bsteh, et al.
Journal of Neurology
|
September 15, 2020
Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis
Tobias Monschein, Sabine Salhofer-Polanyi, Patrick Altmann, et al.
Page
of 26